MOESM5 of Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

Additional file 5: Table S2. Linear regression model for change in BCVA from baseline to Month 12 (FAS).